SMS Pharmaceuticals Limited

BSE:532815 Stock Report

Market Cap: ₹17.1b

SMS Pharmaceuticals Management

Management criteria checks 2/4

SMS Pharmaceuticals' CEO is Ramesh Potluri, appointed in Aug 1990, has a tenure of 34.5 years. total yearly compensation is ₹36.88M, comprised of 81.4% salary and 18.6% bonuses, including company stock and options. directly owns 36.22% of the company’s shares, worth ₹6.19B. The average tenure of the management team and the board of directors is 5.8 years and 2.6 years respectively.

Key information

Ramesh Potluri

Chief executive officer

₹36.9m

Total compensation

CEO salary percentage81.4%
CEO tenure34.5yrs
CEO ownership36.2%
Management average tenure5.8yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ramesh Potluri's remuneration changed compared to SMS Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹593m

Jun 30 2024n/an/a

₹570m

Mar 31 2024₹37m₹30m

₹498m

Dec 31 2023n/an/a

₹361m

Sep 30 2023n/an/a

₹288m

Jun 30 2023n/an/a

₹150m

Mar 31 2023₹31m₹30m

-₹71m

Dec 31 2022n/an/a

-₹42m

Sep 30 2022n/an/a

₹9m

Jun 30 2022n/an/a

₹259m

Mar 31 2022₹38m₹26m

₹622m

Dec 31 2021n/an/a

₹789m

Sep 30 2021n/an/a

₹911m

Jun 30 2021n/an/a

₹791m

Mar 31 2021₹47m₹21m

₹625m

Dec 31 2020n/an/a

₹458m

Sep 30 2020n/an/a

₹319m

Jun 30 2020n/an/a

₹308m

Mar 31 2020₹26m₹20m

₹316m

Dec 31 2019n/an/a

₹386m

Sep 30 2019n/an/a

₹405m

Jun 30 2019n/an/a

₹406m

Mar 31 2019₹32m₹20m

₹400m

Mar 31 2018₹32m₹20m

₹317m

Compensation vs Market: Ramesh's total compensation ($USD425.50K) is above average for companies of similar size in the Indian market ($USD188.49K).

Compensation vs Earnings: Ramesh's compensation has been consistent with company performance over the past year.

CEO

Ramesh Potluri (66 yo)

34.5yrs

Tenure

₹36,875,000

Compensation

Mr. Ramesh Babu Potluri has been the Chairman and Managing Director of SMS Pharmaceuticals Limited since August 30, 1990. Mr. Potluri has pioneered the vision of developing SMS in to one of the leading Pha...

Leadership Team

NamePositionTenureCompensationOwnership
Ramesh Potluri
Chairman & MD34.5yrs₹36.88m36.22%
₹ 6.2b
Lakshmi Tammineedi
Chief Financial Officer7.4yrs₹2.37mno data
Tumma Thirumalesh
Company Secretary & Compliance Officer3yrs₹1.53mno data
Vamsi Potluri
Executive Director4.1yrs₹36.83m15.74%
₹ 2.7b
Y. Rao
Assistant General Manager of HR and Legalno datano datano data
Potluri Kumar
Head of HRD and General Manager of Purchasesno datano datano data

5.8yrs

Average Tenure

61yo

Average Age

Experienced Management: 532815's management team is seasoned and experienced (5.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ramesh Potluri
Chairman & MD34.5yrs₹36.88m36.22%
₹ 6.2b
Vamsi Potluri
Executive Director4.7yrs₹36.83m15.74%
₹ 2.7b
Trilok Potluri
Additional Non-Executive Non-Independent Directorless than a yearno data2.58%
₹ 441.6m
Sarvepalli Srinivas
Non-Executive & Independent Director5.5yrs₹245.00kno data
Shravan Kudaravalli
Non-Executive & Independent Director6.8yrs₹590.00k0.035%
₹ 6.1m
Suresh Gangavarapu
Additional Non-Executive Independent Directorless than a yearno datano data
Sunkara Venkata Shiva Prasad
Non-Executive Non-Independent Directorless than a yearno datano data
Shanti Bolleni
Non-Executive Independent Directorless than a yearno datano data

2.6yrs

Average Tenure

62yo

Average Age

Experienced Board: 532815's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 15:46
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SMS Pharmaceuticals Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research